BACKGROUND. The retinoblastoma-susceptibility (Rb) gene is a prototype tumor-suppressor gene originally isolated from patients with heritable retinoblastoma. This gene encodes a nuclear phosphoprotein whose expression is altered in several types of human tumors. METHODS. We studied the expression of the Rb protein in 44 primary and 12 metastatic high-grade human sarcomas by means of immunohistochemical methods and Western blotting. Computerized image analysis was used to quantify the level of Rb gene product in individual tumor cells. The expression of the Rb gene was then correlated with clinical outcome in the patients with primary tumors. RESULTS. Of the 44 patients with primary sarcomas, 13 (30 percent) had tumors with normal, homogeneous expression of the Rb protein in essentially all tumor cells. Thirty-one patients with primary tumors (70 percent) had altered Rb expression; in 18 (40 percent) the Rb protein was heterogeneously expressed, and in 13 (30 percent) it was detected in fewer than 20 percent of the tumor cells. All 12 of the patients with metastatic sarcomas had altered expression of the Rb protein. When the findings in the patients with primary tumors were correlated with clinical outcome, survival was found to be significantly increased in the patients whose tumors had homogeneous Rb expression, as compared with those with either heterogeneous expression (P = 0.026) or no expression (P = 0.012). CONCLUSIONS. Tumors in which the expression of Rb gene product was decreased were more aggressive than tumors in which this protein was expressed by nearly all cells. The Rb gene product may be an important prognostic variable in patients with these tumors.
Source Information
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
This article has been cited by other articles:
Brennan, M. F.
(2006). Lessons Learned.... Ann. Surg. Oncol.
13: 1322-1328
[Full Text]
Kleinerman, R. A., Tucker, M. A., Tarone, R. E., Abramson, D. H., Seddon, J. M., Stovall, M., Li, F. P., Fraumeni, J. F. Jr
(2005). Risk of New Cancers After Radiotherapy in Long-Term Survivors of Retinoblastoma: An Extended Follow-Up. JCO
23: 2272-2279
[Abstract][Full Text]
Fletcher, O., Easton, D., Anderson, K., Gilham, C., Jay, M., Peto, J.
(2004). Lifetime Risks of Common Cancers Among Retinoblastoma Survivors. JNCI J Natl Cancer Inst
96: 357-363
[Abstract][Full Text]
Lark, A. L., Livasy, C. A., Calvo, B., Caskey, L., Moore, D. T., Yang, X., Cance, W. G.
(2003). Overexpression of Focal Adhesion Kinase in Primary Colorectal Carcinomas and Colorectal Liver Metastases: Immunohistochemistry and Real-Time PCR Analyses. Clin. Cancer Res.
9: 215-222
[Abstract][Full Text]
Lasorella, A., Boldrini, R., Dominici, C., Donfrancesco, A., Yokota, Y., Inserra, A., Iavarone, A.
(2002). Id2 Is Critical for Cellular Proliferation and Is the Oncogenic Effector of N-Myc in Human Neuroblastoma. Cancer Res.
62: 301-306
[Abstract][Full Text]
Hoos, A., Lewis, J. J., Antonescu, C. R., Dudas, M. E., Leon, L., Woodruff, J. M., Brennan, M. F., Cordon-Cardo, C.
(2001). Characterization of Molecular Abnormalities in Human Fibroblastic Neoplasms: A Model for Genotype-Phenotype Association in Soft Tissue Tumors. Cancer Res.
61: 3171-2175
[Abstract][Full Text]
Hoos, A., Urist, M. J., Stojadinovic, A., Mastorides, S., Dudas, M. E., Leung, D. H. Y., Kuo, D., Brennan, M. F., Lewis, J. J., Cordon-Cardo, C.
(2001). Validation of Tissue Microarrays for Immunohistochemical Profiling of Cancer Specimens Using the Example of Human Fibroblastic Tumors. Am. J. Pathol.
158: 1245-1251
[Abstract][Full Text]
Cance, W. G., Harris, J. E., Iacocca, M. V., Roche, E., Yang, X., Chang, J., Simkins, S., Xu, L.
(2000). Immunohistochemical Analyses of Focal Adhesion Kinase Expression in Benign and Malignant Human Breast and Colon Tissues: Correlation with Preinvasive and Invasive Phenotypes. Clin. Cancer Res.
6: 2417-2423
[Abstract][Full Text]
Rabbani, F., Richon, V. M., Orlow, I., Lu, M.-L., Drobnjak, M., Dudas, M., Charytonowicz, E., Dalbagni, G., Cordon-Cardo, C.
(1999). Prognostic Significance of Transcription Factor E2F-1 in Bladder Cancer: Genotypic and Phenotypic Characterization. JNCI J Natl Cancer Inst
91: 874-881
[Abstract][Full Text]
Morente, M. M., Piris, M. A., Abraira, V., Acevedo, A., Aguilera, B., Bellas, C., Fraga, M., Garcia-Del-Moral, R., Gomez-Marcos, F., Menarguez, J., Oliva, H., Sanchez-Beato, M., Montalban, C.
(1997). Adverse Clinical Outcome in Hodgkin's Disease Is Associated With Loss of Retinoblastoma Protein Expression, High Ki67 Proliferation Index, and Absence of Epstein-Barr Virus-Latent Membrane Protein 1 Expression. Blood
90: 2429-2436
[Abstract][Full Text]
Inoue, A., Torigoe, T., Sogahata, K., Kamiguchi, K., Takahashi, S., Sawada, Y., Saijo, M., Taya, Y., Ishii, S.-i., Sato, N., Kikuchi, K.
(1995). 70-kDa Heat Shock Cognate Protein Interacts Directly with the N-terminal Region of the Retinoblastoma Gene Product pRb. J. Biol. Chem.
270: 22571-22576
[Abstract][Full Text]
Previous
